All terms in OBI

Label Id Description
study limitations section IAO_0000631 [A part of a document about biases or short comings related to the study design and execution.]
document part IAO_0000314 [An information content entity that is part of a document.]
study limitations textual entity IAO_0000632 [A textual entity addressing a shortcoming or bias of a study design or execution.]
textual entity IAO_0000300 [A textual entity is a part of a manifestation (FRBR sense), a generically dependent continuant whose concretizations are patterns of glyphs intended to be interpreted as words, formulas, etc.]
materials section IAO_0000633 [A part of a document about the materials required to reproduce the content of the document.]
notes section IAO_0000634 [A part of a document containing typically short notes about the document itself and/or the authors. Often the notes section contains subsections related to funding, competing interests, ethical approval, etc.]
keywords section IAO_0000630 [A part of a document where keywords selected by the author to categorize the major theme(s) of a document are listed.]
radioactivity detection assay measuring half maximal effective concentration [EC50] to determine direct binding of a cell-lysate-MHC:ligand complex OBI_0001516 [A radioactivity detection assay that measures half maximal effective concentration (EC50) to detect the direct binding of a cell-lysate-MHC molecule with a ligand.]
binding assay using radioactivity detection OBI_0001491 [A binding assay that uses radioactivity detection as an indicator of binding.]
assay measuring the half maximal effective concentration [EC50] of a MHC:ligand complex OBI_0001991 [A MHC binding constant determination assay measuring half maximal effective concentration (EC50).]
radioactivity detection assay measuring half maximal inhibitory concentration [IC50] to determine competitive binding of a cell-bound-MHC:ligand complex OBI_0001517 [A radioactivity detection assay that measures half maximal inhibitory concentration (IC50) to detect the loss of binding of a known reference ligand to cell-bound-MHC due to competition by the ligand under investigation.]
assay measuring the half maximal inhibitory concentration [IC50] of a MHC:ligand complex OBI_0001992 [A MHC binding constant determination assay measuring half maximal inhibitory concentration (IC50).]
epitope specific tumor necrosis factor (ligand) superfamily member 11 production by T cells OBI_0001518 [A process of tumor necrosis factor (ligand) superfamily member 11 production by T cells resulting from the recognition of a T cell epitope.]
tumor necrosis factor (ligand) superfamily member 11 production GO_0072535 [The appearance of tumor necrosis factor superfamily member 11 (TNFSF11; RANKL) due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.]
epitope specific tumor necrosis factor superfamily cytokine production by T cells OBI_0001351 [A process of tumor necrosis factor superfamily cytokine production by T cells resulting from the recognition of a T cell epitope.]
fluorescence detection assay measuring direct binding of a cell-lysate-MHC:ligand complex OBI_0001519 [A fluorescence detection assay that detects direct binding of a cell-lysate-MHC molecule with a ligand.]
binding assay using fluorescence detection OBI_0001499 [A binding assay that uses fluorescence detection as an indicator of binding.]
assay measuring binding of a cell-lysate-MHC:ligand complex OBI_0001579 [A qualitative binding assay that detects the binding of a cell-lysate-MHC molecule with a ligand.]
CBC with manual differential venous blood WBC count assay OBI_2100100 [A cytometry assay that measures the count of WBCs in venous blood as part of a CBC with manual differential order]
cytometry assay OBI_0001977 [An assay that counts and/or measures characteristics of cells.]